Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies

W Löscher - Epilepsy research, 2016 - Elsevier
Animal seizure and epilepsy models continue to play an important role in the early discovery
of new therapies for the symptomatic treatment of epilepsy. Since 1937, with the discovery of …

Predicting drug extraction in the human gut wall: assessing contributions from drug metabolizing enzymes and transporter proteins using preclinical models

SA Peters, CR Jones, AL Ungell, OJD Hatley - Clinical pharmacokinetics, 2016 - Springer
Intestinal metabolism can limit oral bioavailability of drugs and increase the risk of drug
interactions. It is therefore important to be able to predict and quantify it in drug discovery …

[BOOK][B] Animal models in toxicology

SC Gad - 2006 - taylorfrancis.com
Reflecting more than a decade's worth of changes, Animal Models in Toxicology, Second
Edition is a practical guide to the common statistical problems encountered in toxicology and …

CAR T-cell therapy: toxicity and the relevance of preclinical models

M Kalaitsidou, G Kueberuwa, A Schütt… - Immunotherapy, 2015 - Taylor & Francis
Chimeric antigen receptor (CAR) T cells form part of a broad wave of immunotherapies that
are showing promise in early phase cancer clinical trials. This clinical delivery has been …

Comparison of xenobiotic-metabolising human, porcine, rodent, and piscine cytochrome P450

V Burkina, MK Rasmussen, N Pilipenko… - Toxicology, 2017 - Elsevier
Cytochrome P450 proteins (CYP450s) are present in most domains of life and play a critical
role in the metabolism of endogenous compounds and xenobiotics. The effects of exposure …

Adverse geriatric outcomes secondary to polypharmacy in a mouse model: the influence of aging

A Huizer-Pajkos, AE Kane, SE Howlett… - … Series A: Biomedical …, 2016 - academic.oup.com
We aimed to develop a mouse model of polypharmacy, primarily to establish whether short-
term exposure to polypharmacy causes adverse geriatric outcomes. We also investigated …

Systematic health risks assessment of chiral fungicide famoxadone: Stereoselectivities in ferroptosis-mediated cytotoxicity and metabolic behavior

S **ao, J Cui, J Yang, H Hou, J Yao, X Ma… - Journal of Hazardous …, 2024 - Elsevier
Famoxadone is a chiral fungicide frequently found in the environment and agricultural
products. However, the health risks of famoxadone enantiomers are not well understood …

Assembly of hepatocyte spheroids using magnetic 3D cell culture for CYP450 inhibition/induction

PK Desai, H Tseng, GR Souza - International journal of molecular …, 2017 - mdpi.com
There is a significant need for in vitro methods to study drug-induced liver injury that are
rapid, reproducible, and scalable for existing high-throughput systems. However, traditional …

Significantly Improved Pharmacokinetics Enhances In Vivo Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of …

Y Zhao, MH Lee, P Paderu, A Lee… - Antimicrobial agents …, 2018 - Am Soc Microbiol
ABSTRACT APX001 is a first-in-class, intravenous and orally available, broad-spectrum
antifungal agent in clinical development for the treatment of life-threatening invasive fungal …

Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science

DJ Antoine, DP Williams, BK Park - Expert opinion on drug …, 2008 - Taylor & Francis
Drug-induced liver injury (DILI) represents a major impediment to the development of new
drugs and is a leading cause of drug withdrawal. The occurrence of hepatotoxicity has been …